查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1901514

失眠补充剂市场：按剂型、来源、产品、配销通路、国家和地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Insomnia Supplements Market, By Dosage Form, By Source, By Product, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年失眠补充剂市场规模价值 43.5698 亿美元，从 2025 年到 2032 年以 13.2% 的复合年增长率成长。

失眠补充剂是一种无需处方即可购买的产品，旨在帮助人们更快入睡、延长睡眠时间并改善整体睡眠品质。它们通常含有褪黑素、镁、草药萃取物、胺基酸或大麻素等成分，这些成分能够促进放鬆并调节睡眠週期。对于那些寻求天然或温和方法来改善偶发性或慢性睡眠问题的消费者而言，这些补充剂提供了一种非处方选择。不断上升的压力水平和人们对天然助眠产品的日益青睐正在推动失眠补充剂市场的发展。一个关键趋势是使用将褪黑素与植物成分结合的多功能配方，以提高其功效。然而，监管不力以及对产品品质的担忧仍然限制着市场成长。儘管如此，不断增长的电子商务分销管道和对个人化睡眠解决方案的需求为品牌创新和拓展更广泛的消费群体提供了巨大的机会。

失眠补充剂市场－市场动态

慢性病盛行率上升将推动市场成长

慢性病盛行率的上升预计将推动失眠补充剂市场的未来成长。慢性病是指持续三个月或更长时间且病情可能随时间恶化的疾病。患有心血管疾病、糖尿病和慢性疼痛等慢性疾病的患者，常伴随失眠或其他睡眠相关问题。这种盛行率的上升催生了对有效失眠治疗和管理策略的需求，从而推动了睡眠障碍相关产品和服务市场的发展。根据美国国家医学图书馆下属的国家生物技术资讯中心（NCBI）的数据显示，到2050年，全球将有1.4266亿人患有慢性病，高于2020年的7,152.2万人。因此，慢性病盛行率的上升推动了失眠补充剂产业的成长。

失眠补充剂市场区隔分析：

全球失眠补充剂市场按剂型、来源、产品、配销通路和地区细分。

根据产品细分市场，褪黑素类补充剂是失眠补充剂市场中最受欢迎的细分市场，这主要得益于消费者对非成瘾性助眠产品的需求不断增长。褪黑素能够调节昼夜节律，影响血清素等情绪调节神经传导物质。这种双重功效，加上其促进睡眠的能力，使其成为焦虑相关睡眠障碍或一般压力族群的理想选择。由于送货上门的便利性和日益增强的健康意识，褪黑素在网路药局和电商平台的销售量显着增长。 2023年1月，宝洁健康在印度推出了Vicks ZzzQuil NATURA，这是一款添加褪黑素的软糖，旨在帮助用户快速入睡，且不会导致隔天困倦。该产品还含有维生素B6，有助于减轻疲劳感，并添加了天然洋甘菊和熏衣草成分，以促进放鬆。此次产品上市满足了一项重大需求，因为宝洁健康发现，只有 15% 的印度人晚上能睡个好觉，而近 60% 的人偶尔会失眠。

以剂型划分，胶囊在失眠补充品市场应用广泛，凭藉其便利性、剂量可控性和消费者偏好度高，已成为最大的细分市场。胶囊更容易吞嚥和崩解，使褪黑素、缬草根和L-茶氨酸等活性成分能够更快被吸收。这种剂型也便于进行精确配方和控释，因此深受寻求可靠稳定效果的生产商和使用者的青睐。此外，胶囊的保质期更长，通常不含添加糖或人工香料，符合清洁标籤的趋势。 2024年12月，Sleepinox.com推出了一款天然睡眠补充剂，配方包含缬草根、琉璃苣、南非醉茄和甘氨酸镁。该产品以90粒胶囊的瓶装形式在网路上销售，旨在促进安稳、恢復精力的睡眠。

失眠补充剂市场—地域分布洞察

北美是失眠补充剂（ED​​药物）市场的重要收入来源地，这主要归功于该地区睡眠障碍的高发生率以及民众日益增强的健康意识。根据美国国家老化委员会统计，美国有5,000万至7,000万人患有慢性睡眠障碍，其中以失眠最为常见。如此高的需求促使企业不断创新，拓展产品线，以满足睡眠不足的消费者的需求。例如，GNC于2023年5月推出了其预防营养睡眠支援产品，该产品专注于改善认知功能，特别是睡眠、注意力和压力管理。人们对健康和保健日益重视，以及线上药局的便利性，都有助于推动该地区市场的成长。

美国失眠补充剂市场—国家概况

由于高压力、快节奏的生活方式以及人们对睡眠健康的日益关注，美国已成为失眠补充剂市场最大、最具活力的市场之一。消费者对天然、非处方助眠产品（例如褪黑素、镁和草药混合物）的强烈需求，正在推动市场成长。根据美国睡眠医学会最近的一项调查，约30%的美国成年人表示入睡或保持睡眠困难，10%的人患有慢性失眠，12%的人被医生诊断为慢性失眠。这些产品的广泛普及推高了对有效非处方补充剂的需求，而强劲的线上零售渗透率和人们对个人化健康产品日益增长的兴趣也进一步促进了这一需求。

目录

第一章：失眠补充剂市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：失眠补充剂市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：失眠补充剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：失眠补充剂市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：失眠补充剂市场概况

  • 2024年失眠补充剂市占率分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：失眠补充剂市场：以剂型划分

  • 概述
    • 细分市场占有率分析：按剂型
    • 片剂
    • 液体
    • 胶囊
    • 粉末
    • 其他的

第八章：失眠补充剂市场：依来源划分

  • 概述
    • 细分市场占有率分析：按来源
    • 自然的
    • 合成的

第九章：失眠补充剂市场：依产品分类

  • 概述
    • 细分市场占有率分析：依产品
    • 矿物
    • 缬草根
    • 维他命
    • 褪黑素
    • 其他的

第十章：失眠补充剂市场：依配销通路划分

  • 概述
    • 细分市场占有率分析：按来源
    • 医院药房
    • 网路药局
    • 零售药局
    • 专卖店

第十一章：失眠补充品市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章：主要供应商分析：失眠补充剂产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Nature's Bounty
    • Nestle
    • Zarbee's Naturals
    • Olly
    • Herbalife Nutrition Ltd
    • Hims & Hers Health, Inc.
    • NOW Foods
    • Bayer
    • Herb Pharm
    • Natrol, LLC
    • Others

第十三章：360度AnalystView

简介目录
Product Code: ANV5824

Insomnia Supplements Market size was valued at US$ 4,356.98 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.

Insomnia supplements are over-the-counter products that help people fall asleep faster, stay asleep longer, and sleep better overall. They usually contain ingredients like melatonin, magnesium, herbal extracts, amino acids, or cannabinoids, which promote relaxation and regulate sleep cycles. These supplements provide a non-prescription alternative for people looking for natural or gentle support for occasional or chronic sleep problems. Rising stress levels and a growing preference for natural sleep aids are driving the Insomnia Supplements market. A key trend is the use of multifunctional formulas that combine melatonin with botanicals to increase efficacy. However, inconsistent regulatory oversight and concerns about product quality continue to limit market growth. Despite this, growing e-commerce distribution and demand for personalized sleep solutions offer significant opportunities for brands to innovate and reach a larger consumer base.

Insomnia Supplements Market- Market Dynamics

Rising Prevalence of Chronic Diseases to Drive Market Growth

The rising prevalence of chronic diseases is expected to drive future growth in the insomnia supplements market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Individuals with chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, frequently have insomnia or other sleep-related problems as a comorbidity. This increased prevalence creates a demand for effective insomnia treatments and management strategies, which drives the market for sleep disorder-related products and services. According to the National Centre for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people living with chronic diseases by 2050, up from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases fuels the growth of the insomnia supplements industry.

Insomnia Supplements Market- Segmentation Analysis:

The Global Insomnia Supplements Market is segmented by Dosage Form, Source, Product, Distribution Channel and Region.

According to the product segment, Melatonin-based supplements are the most popular segment of the insomnia supplements market, driven by rising consumer demand for non-addictive sleep aids. Melatonin regulates circadian rhythms and affects mood-regulating neurotransmitters such as serotonin. This dual benefit, combined with its ability to induce sleep, makes it an appealing option for people experiencing anxiety-related sleep disturbances or general stress. Melatonin sales increased significantly at online pharmacies and e-commerce platforms, owing to the convenience of home delivery and growing health awareness. In January 2023, P&G Health launched Vicks ZzzQuil NATURA in India, a melatonin-infused gummy designed to help users fall asleep quickly without causing drowsiness the next day. The product also contains vitamin B6, which helps to reduce tiredness and fatigue, and it is infused with natural chamomile and lavender to promote relaxation. This launch addresses a significant need, as P&G Health discovered that only 15% of Indians get adequate sleep at night, with nearly 60% experiencing occasional sleeplessness.

By Dosage Form, Capsules are widely used in the insomnia supplement market, emerging as the largest segment due to their convenience, controlled dosage, and high consumer preference. Capsules are easier to swallow and disintegrate, allowing for faster absorption of active ingredients such as melatonin, valerian root, and L-theanine. This form factor also allows for precise formulation and controlled-release options, making it popular with manufacturers and users looking for dependable and consistent results. Additionally, capsules have longer shelf lives and are frequently free of added sugars or artificial flavors, which aligns with clean-label trends. In December 2024, Sleepinox.com launched a natural sleep supplement formulated with valerian root, borage, ashwagandha and magnesium glycinate. The product is available online in a bottle with 90 capsules and aims to promote restful, rejuvenating sleep.

Insomnia Supplements Market- Geographical Insights

North America is a significant revenue-generating region in the Insomnia Supplements (ED) drugs market, owing primarily to the high prevalence of sleep disorders and rising health awareness among its population. According to the National Council on Aging, 50 to 70 million people in the United States have chronic sleep disorders, with insomnia being the most common. This high demand has prompted businesses to innovate and broaden their product offerings to meet the needs of sleep-deprived customers. For instance, in May 2023, GNC introduced its Preventive Nutrition Sleep Support products, which focus on improving cognitive function, particularly sleep, focus, and stress. The growing emphasis on health and wellness, as well as the convenience of online pharmacies, helps to drive market growth in this region.

United States Insomnia Supplements Market- Country Insights

The United States is one of the largest and most dynamic markets for insomnia supplements, due to high stress levels, hectic lifestyles, and a growing awareness of sleep health. The strong consumer shift toward natural, non-prescription sleep aids such as melatonin, magnesium, and herbal blends is driving market growth. According to a recent survey conducted by the American Academy of Sleep Medicine, approximately 30% of adults in the United States report difficulty falling or staying asleep, 10% suffer from chronic insomnia, and 12% have been medically diagnosed with chronic insomnia. This widespread availability drives up demand for effective over-the-counter supplements, which is bolstered by strong online retail penetration and growing interest in personalized wellness products.

Insomnia Supplements Market- Competitive Landscape:

The competitive landscape of the insomnia supplements market is characterized by the presence of numerous players, ranging from multinational pharmaceutical corporations to small and medium-sized businesses specializing in natural and herbal products. The market is highly fragmented, with companies seeking a competitive advantage through product innovation, quality, and marketing strategies. The growing demand for natural and safe sleep aid products has resulted in a surge of new entrants and the introduction of novel formulations, escalating competition.

Recent Developments:

In October 2025, Slumber introduced its Pure Sleep fast-acting gummies, which contain 20 mg of CBN and Azuca's Time Infusion(R) technology for rapid onset in minutes. The company developed the formula to help customers fall asleep faster, stay asleep longer, and wake up feeling refreshed.

In August 2025, AG1 introduced AGZ, a melatonin-free drink mix containing Magtein, saffron, and L-theanine that promotes relaxation and restorative sleep. The product was launched to support evening routines and supplement AG1's morning formula with all-day wellness benefits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL INSOMNIA SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Nature's Bounty
  • Nestle
  • Zarbee's Naturals
  • Olly
  • Herbalife Nutrition Ltd
  • Hims & Hers Health, Inc.
  • NOW Foods
  • Bayer
  • Herb Pharm
  • Natrol, LLC
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Liquid
  • Capsules
  • Powders
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Minerals
  • Valerian root
  • Vitamin
  • Melatonin
  • Others

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Specialty Stores

GLOBAL INSOMNIA SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Insomnia Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Insomnia Supplements Market Snippet by Dosage Form
    • 2.1.2. Insomnia Supplements Market Snippet by Source
    • 2.1.3. Insomnia Supplements Market Snippet by Product
    • 2.1.4. Insomnia Supplements Market Snippet by Distribution Channel
    • 2.1.5. Insomnia Supplements Market Snippet by Country
    • 2.1.6. Insomnia Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Insomnia Supplements Key Market Trends

  • 3.1. Insomnia Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Insomnia Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Insomnia Supplements Market Opportunities
  • 3.4. Insomnia Supplements Market Future Trends

4. Insomnia Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Insomnia Supplements Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Insomnia Supplements Market Landscape

  • 6.1. Insomnia Supplements Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Insomnia Supplements Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
    • 7.1.2. Tablets
    • 7.1.3. Liquid
    • 7.1.4. Capsules
    • 7.1.5. Powders
    • 7.1.6. Others

8. Insomnia Supplements Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 8.1.2. Natural
    • 8.1.3. Synthetic

9. Insomnia Supplements Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 9.1.2. Minerals
    • 9.1.3. Valerian root
    • 9.1.4. Vitamin
    • 9.1.5. Melatonin
    • 9.1.6. Others

10. Insomnia Supplements Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Online Pharmacies
    • 10.1.4. Retail Pharmacies
    • 10.1.5. Specialty Stores

11. Insomnia Supplements Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Insomnia Supplements Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Insomnia Supplements Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Insomnia Supplements Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Insomnia Supplements Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Insomnia Supplements Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Insomnia Supplements Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Nature's Bounty
    • 12.2.2. Nestle
    • 12.2.3. Zarbee's Naturals
    • 12.2.4. Olly
    • 12.2.5. Herbalife Nutrition Ltd
    • 12.2.6. Hims & Hers Health, Inc.
    • 12.2.7. NOW Foods
    • 12.2.8. Bayer
    • 12.2.9. Herb Pharm
    • 12.2.10. Natrol, LLC
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us